Hamad Medical Corporation-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment

    Journal of Allergy and Clinical Immunology, Vol. 142, Núm. 2, pp. 605-617.e7